Contribution: Industrial Research Assistance Program – Contributions to Firms
ChipCare Corporation
$42,900.00
COVID19 T-cell testing opportunities
FY 2020-21 · 2020-10-01
Summary
Growing evidence suggests that T-cell immunity against the virus is long-lasting and protective against re-infection. ChipCare is investigating a potential assay that will help identify individuals who have been exposed to a SARS corona virus in the past and may therefore have immunity to SARS-CoV2. The purpose of this project is to establish the clinical need, research appropriate markers, define the market opportunity and requirements for such an assay and to assess the suitability of such an assay for use in point-of-care settings using ChipCare’s platform.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Toronto|Toronto, Ontario, Canada
Recipient Type
For-profit organization
Business Number
801903295
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2020-10-01 | 2020-21 | $42,900.00 |
| 1 | 2020-10-01 | 2020-21 | $42,900.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 105 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 105 jours.
Agreement End Date
2021-05-31
Agreement Number
957327
Agreement Start Date
2020-10-01
Agreement Title
COVID19 T-cell testing opportunities
Agreement Title (French)
Possibilités de test des lymphocytes T contre la COVID-19
Agreement Type
Contribution
Agreement Value
$42,900.00
Amendment Date
2021-01-15
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Growing evidence suggests that T-cell immunity against the virus is long-lasting and protective against re-infection. ChipCare is investigating a potential assay that will help identify individuals who have been exposed to a SARS corona virus in the past and may therefore have immunity to SARS-CoV2. The purpose of this project is to establish the clinical need, research appropriate markers, define the market opportunity and requirements for such an assay and to assess the suitability of such an assay for use in point-of-care settings using ChipCare’s platform.
Description (French)
De plus en plus de preuves suggèrent que l'immunité des lymphocytes T contre le virus est durable et protège contre la réinfection. ChipCare étudie un test potentiel qui aidera à repérer les personnes qui ont été exposées à un virus corona du SRAS dans le passé et qui pourraient donc être immunisées contre le SRAS-CoV2. Le but de ce projet est d'établir le besoin clinique, de rechercher des indicateurs appropriés, de définir les possibilités et les exigences du marché pour un tel test et d'évaluer la pertinence d'un tel test aux fins d'utilisation dans les points de service en recourant à la plate-forme de ChipCare.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Spadina--Fort York
Federal Riding (French)
Spadina--Fort York
Federal Riding Number
35101
NAICS Code
33911
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
801903295
Recipient City
Toronto|Toronto
Recipient Country
CA
Recipient Legal Name
ChipCare Corporation
Recipient Postal Code
M5V 3B1
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2020-2021-Q3-957327
